File(s) under permanent embargo
Reason: The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.
Obesity and risk of COVID-19: analysis of UK Biobank
resulting complications, less is known about the relative importance of related lifestyle factors. Obesity in particular is associated with
impaired pulmonary function, a suppressed immune system and has been identified as a risk factor in previous infectious outbreaks.
Obesity also appears to be prevalent in subjects with COVID-19. However, as recently highlighted, there is a lack of information
regarding the nature of association between body mass index (BMI) and COVID-19. In order to inform this area, we investigated the association between obesity and laboratory confirmed COVID-19 within UK Biobank (application number 36371). Our hypothesis was that BMI and waist circumference would be independently associated with COVID19.
Funding
This work was supported by the NIHR Leicester Biomedical Research Centre and NIHR Applied Research Centre East Midlands. Data was analysed using UK Biobank application number 36371
History
Citation
Please cite this article as: Yates T, Razieh C, Zaccardi F, Davies MJ, Khunti K, Obesity and risk of COVID-19: analysis of UK Biobank, Primary Care Diabetes (2020), doi: https://doi.org/10.1016/j.pcd.2020.05.011Version
- AM (Accepted Manuscript)